Clinical Trial

SAHaRA: A Randomized Controlled Trial

Study Description

SAHaRA: A Randomized Controlled Trial

The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Liberal RBC Transfusion Strategy

RBC transfusion is triggered by a Hemoglobin value of ≤100g/L

Restrictive RBC Transfusion Strategy

Optional RBC transfusion is triggered by a Hemoglobin value of ≤80g/L

Additional Information

Official Study Title

Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial

Clinical Trial ID

NCT03309579

ParticipAid ID

lej1Wd